Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah Medical Organization and Berlin’s Charité University Hospital Sign Cooperation Agreement for Pediatrics and Neuroscience


As academic institutions, the Hadassah University Medical Center and the Charité University Hospital of Berlin have agreed to work closely to advance teaching and research, with emphasis on pediatrics and the neurosciences.

The two hospitals will work to strengthen and intensify scientific contacts to "build a healthy world together." Plans are under way for research exchanges among doctors, scientists, and students in both partner facilities, as well as for development of joint research projects. Prof. Dr. Anette Grünters Kielisch, Dean of Charité, stated that she is very proud and happy to work with the Hadassah Medical Center and to link the manifold capacities and skills of the two facilities. "Together," she said, "we can react much faster to medical challenges."

Representatives from each institution participated in joint talks to define 10 projects in the fields of pediatrics and neuroscience on which they can collaborate. These projects will be announced in the near future.

The concept for this initiative came from Gady Gronich, Senior Director of Hadassah Germany, who with the help and leadership of Prof. Eitan Kerem, head of Hadassah's Division of Pediatrics, and his Hadassah colleagues (Dr. Arzy Shahar, Prof. Benjamin Bar-Oz, Prof. Tamir Ben-Hur, Prof. Dan Engelhard, Dr. Netta Levin, Dr. Adi Vaknin, and Dr. David Zangen) made this project possible.

Regine Sixt from Sixt car rental and leasing company, provided generous support for the project. Ms. Sixt sponsored this signing event together with Teva Pharmaceuticals of Israel.

Date: 4/18/2014


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America